含不同剂量去甲氧柔红霉素的IA方案诱导治疗成人初发急性髓系白血病的疗效和安全性研究

OBJECTIVE: To investigate the efficacy and safety of IA regimen which contains idarubicin (IDA) 8 mg/m(2), 10 mg/m(2) or 12 mg/m(2) as induction chemotherapy for adult patients with de-novo acute myeloid leukemia (AML). METHODS: A total of 1 215 newly diagnosed adult AML patients, ranging from May 2...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2017
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342198/
https://www.ncbi.nlm.nih.gov/pubmed/29365393
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.12.003

Ejemplares similares

Ejemplares similares